Literature DB >> 20083475

The spectrum of FSGS: does pathology matter?

Agnes B Fogo.   

Abstract

Mesh：

Year:  2010        PMID： 20083475     DOI： 10.1093/ndt/gfp745

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

Review 1.  Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.

Authors:  Kirk N Campbell; James A Tumlin
Journal:  Am J Nephrol       Date:  2018-05-31       Impact factor: 3.754

2.  Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression.

Authors:  Sabrina Giglio; Aldesia Provenzano; Benedetta Mazzinghi; Francesca Becherucci; Laura Giunti; Giulia Sansavini; Fiammetta Ravaglia; Rosa Maria Roperto; Silvia Farsetti; Elisa Benetti; Mario Rotondi; Luisa Murer; Elena Lazzeri; Laura Lasagni; Marco Materassi; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2014-07-24       Impact factor: 10.121

3.  Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.

Authors:  Sima Babayeva; Michelle Miller; Yulia Zilber; Reyhan El Kares; Chantale Bernard; Martin Bitzan; Paul Goodyer; Elena Torban
Journal:  Pediatr Nephrol       Date:  2011-03-06       Impact factor: 3.714

4.  Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis.

Authors:  Jarcy Zee; Qian Liu; Abigail R Smith; Jeffrey B Hodgin; Avi Rosenberg; Brenda W Gillespie; Lawrence B Holzman; Laura Barisoni; Laura H Mariani
Journal:  J Am Soc Nephrol       Date:  2022-05-17       Impact factor: 14.978

5.  Reverse Phenotyping after Whole-Exome Sequencing in Steroid-Resistant Nephrotic Syndrome.

Authors:  Samuela Landini; Benedetta Mazzinghi; Francesca Becherucci; Marco Allinovi; Aldesia Provenzano; Viviana Palazzo; Fiammetta Ravaglia; Rosangela Artuso; Emanuele Bosi; Stefano Stagi; Giulia Sansavini; Francesco Guzzi; Luigi Cirillo; Augusto Vaglio; Luisa Murer; Licia Peruzzi; Andrea Pasini; Marco Materassi; Rosa Maria Roperto; Hans-Joachim Anders; Mario Rotondi; Sabrina Rita Giglio; Paola Romagnani
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-12       Impact factor: 8.237

Review 6.  The Impact of Histologic Variants on FSGS Outcomes.

Authors:  Kristin Meliambro; Monica Schwartzman; Paolo Cravedi; Kirk N Campbell
Journal:  Int Sch Res Notices       Date:  2014-10-29

7.  Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis.

Authors:  Alberto Ortiz; Steve Kanters; Alaa Hamed; Pronabesh DasMahapatra; Eugene Poggio; Manish Maski; Mario Aguiar; Elvira Ponce; Jeroen P Jansen; Dieter Ayers; Rachel Goldgrub; Robert J Desnick
Journal:  Clin Kidney J       Date:  2020-05-22

8.  Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients.

Authors:  Marianna Lucafò; Simona Granata; Erik J Bonten; Robert McCorkle; Gabriele Stocco; Chiara Caletti; Davide Selvestrel; Alessio Cozzarolo; Chan Zou; Eva Cuzzoni; Andrea Pasini; Giovanni Montini; Giovanni Gambaro; Giuliana Decorti; William Evans; Gianluigi Zaza
Journal:  Clin Transl Sci       Date:  2021-01-25       Impact factor: 4.689
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.